Saraa Basaria concentrates her litigation practice on employment law, commercial disputes, and criminal defense. She has successfully tried civil and criminal cases, most recently obtaining an eviction order on behalf of a landlord in a dispute involving a commercial tenant. In an employment law matter, Ms. Basaria persuaded a federal judge pre-trial to dismiss a bias lawsuit filed under Title IX and Massachusetts anti-discrimination laws by an applicant who fell into four protected categories and was denied admission to graduate school programs at a university. Ms. Basaria is dedicated to pro bono work and has represented a number of clients on a pro bono basis.
Prior to joining the firm, Ms. Basaria was a civil litigation attorney at a national law firm where she represented clients in a variety of matters, including commercial litigation, construction litigation, professional liability, land use/zoning litigation, and employment disputes and counseling. She is also a former public defender, having tried jury and bench trials, and argued substantive motions in court.
Ms. Basaria was honored by the Boston Bar Association with the 2020 President's Award for her work as part of a consortium of lawyers from the public and private sector who collectively donated their time and efforts to represent incarcerated individuals at the height of the COVID pandemic.
She is past president of the South Asian Bar Association of Greater Boston, and was a member of the Board of Directors of the South Asian Bar Association of North America (2016-2017). Ms. Basaria currently serves as Secretary on the Board of Trustees of the South Asian Bar Association of North America Foundation. She is a 2017 graduate of the Massachusetts Bar Association's Leadership Academy, and currently serves as Treasurer of the MBA's Young Lawyers Division's Board of Directors, and as a member of the MBA's Diversity Task Force.
Ms. Basaria currently serves on Todd & Weld's Diversity Committee. She is conversational in Urdu, Hindi and Spanish.
Todd & Weld COVID-19 Update.